MannKind Corp. (MNKD)
3.95
-0.11
(-2.71%)
USD |
NASDAQ |
Aug 28, 16:00
3.955
0.00 (0.00%)
After-Hours: 20:00
MannKind Cash and Short Term Investments (Quarterly) : 111.13M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 111.13M |
| March 31, 2026 | 133.86M |
| December 31, 2025 | 171.35M |
| September 30, 2025 | 260.04M |
| June 30, 2025 | 178.98M |
| March 31, 2025 | 181.54M |
| December 31, 2024 | 197.26M |
| September 30, 2024 | 251.59M |
| June 30, 2024 | 247.76M |
| March 31, 2024 | 300.73M |
| December 31, 2023 | 295.10M |
| September 30, 2023 | 141.02M |
| June 30, 2023 | 144.35M |
| March 31, 2023 | 166.14M |
| December 31, 2022 | 170.85M |
| September 30, 2022 | 165.05M |
| June 30, 2022 | 154.16M |
| March 31, 2022 | 162.45M |
| December 31, 2021 | 204.12M |
| September 30, 2021 | 139.05M |
| June 30, 2021 | 162.49M |
| March 31, 2021 | 276.95M |
| December 31, 2020 | 67.16M |
| September 30, 2020 | 52.71M |
| June 30, 2020 | 63.54M |
| Date | Value |
|---|---|
| March 31, 2020 | 39.18M |
| December 31, 2019 | 50.20M |
| September 30, 2019 | 50.37M |
| June 30, 2019 | 38.19M |
| March 31, 2019 | 59.82M |
| December 31, 2018 | 71.68M |
| September 30, 2018 | 10.97M |
| June 30, 2018 | 26.70M |
| March 31, 2018 | 27.23M |
| December 31, 2017 | 48.36M |
| September 30, 2017 | 20.09M |
| June 30, 2017 | 43.38M |
| March 31, 2017 | 47.98M |
| December 31, 2016 | 23.24M |
| September 30, 2016 | 35.53M |
| June 30, 2016 | 63.73M |
| March 31, 2016 | 27.65M |
| December 31, 2015 | 59.07M |
| September 30, 2015 | 32.93M |
| June 30, 2015 | 107.19M |
| March 31, 2015 | 120.84M |
| December 31, 2014 | 120.84M |
| September 30, 2014 | 172.46M |
| June 30, 2014 | 41.21M |
| March 31, 2014 | 35.76M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| United Therapeutics Corp. | 2.662B |
| ACADIA Pharmaceuticals, Inc. | 956.47M |
| Gilead Sciences, Inc. | 4.882B |
| Vertex Pharmaceuticals, Inc. | 7.863B |
| Ocugen, Inc. | 100.05M |